Table 1.
Patient baseline characteristics.
| Factors | B-I (n=95) | B-II (n=36) | R-Y (n=114) | P |
|---|---|---|---|---|
| Gender | 0.269 | |||
| Male | 76 (80.00%) | 24 (66.67%) | 88 (77.19%) | |
| Female | 19 (20.00%) | 12 (33.33%) | 26 (22.81%) | |
| Age (y) | 0.066 | |||
| ≤65 | 51 (53.68%) | 13 (36.11%) | 45 (39.47%) | |
| >65 | 44 (46.32%) | 23 (63.89%) | 69 (60.53%) | |
| NRS 2002 score | 0.243 | |||
| 1-2 | 72 (75.79%) | 22 (61.11%) | 71 (62.28%) | |
| 3-4 | 19 (20.00%) | 11 (30.56%) | 33 (28.95%) | |
| 5-6 | 4 (4.21%) | 3 (8.33%) | 10 (8.77%) | |
| ASA grade | 0.096 | |||
| 1-2 | 76 (80.00%) | 24 (66.67%) | 95 (83.33%) | |
| 3-4 | 19 (20.00%) | 12 (33.33%) | 19 (16.67%) | |
| Hypertension | 0.277 | |||
| Yes | 29 (30.53%) | 13 (36.11%) | 47 (41.23%) | |
| No | 66 (69.47%) | 23 (63.89%) | 67 (58.77%) | |
| Diabetes mellitus | 0.195 | |||
| Yes | 14 (14.74%) | 10 (27.78%) | 25 (21.93%) | |
| No | 81 (85.26%) | 26 (72.22%) | 89 (78.07%) | |
| Previous abdominal surgery | 0.395 | |||
| Yes | 10 (10.53%) | 7 (19.44%) | 13 (11.40%) | |
| No | 85 (89.47%) | 29 (80.56%) | 10 (8.77%) | |
| Tumor location | ||||
| Cardia | 0 (0.00%) | 0 (0.00%) | 38 (33.33%) | <0.001* |
| body | 83 (87.37%) | 33 (91.67%) | 35 (30.70%) | |
| Antrum | 10 (10.53%) | 3 (8.33%) | 34 (29.82%) | |
| Total | 1 (1.05%) | 0 (0.00%) | 7 (6.14%) | |
| Differentiated degree | 0.347 | |||
| Differentiated | 69 (72.63%) | 29 (80.56%) | 88 (77.19%) | |
| Undifferentiated | 8 (8.42%) | 2 (5.56%) | 14 (12.28%) | |
| Signet ring carcinoma | 18 (18.95%) | 5 (13.89%) | 12 (10.53%) | |
| Pathological type | 0.085 | |||
| Ulcerative type | 83 (87.37%) | 35 (97.22%) | 97 (85.09%) | |
| Non-ulcerative type | 12 (12.63%) | 1 (2.78%) | 17 (14.91%) | |
| TNM stage | <0.001* | |||
| I | 50 (52.63%) | 7 (19.44%) | 25 (21.93%) | |
| II | 20 (21.05%) | 11 (30.56%) | 32 (28.07%) | |
| III | 25 (26.32%) | 18 (50.00%) | 57 (50.00%) | |
| Combined organ resection | 0.002* | |||
| Yes | 1 (1.05%) | 2 (5.56%) | 14 (12.28%) | |
| No | 94 (98.95%) | 34 (94.44%) | 10 (8.77%) | |
| Laparoscopic gastrectomy | 0.002* | |||
| Yes | 33 (34.74%) | 3 (8.33%) | 21 (18.42%) | |
| No | 62 (65.26%) | 33 (91.67%) | 93 (81.58%) | |
| Postoperative complications | 0.026* | |||
| Yes | 23 (24.21%) | 18 (50.00%) | 48 (42.11%) | |
| No | 72 (75.79%) | 18 (50.00%) | 66 (57.89%) |
BMI body mass index, ASA American Society of Anesthesiologists, NRS 2002 nutritional risk screening 2002, TNM tumor-node-metastasis.
The values given are number of patients and values in parentheses are percentages.
*Represent P < 0.05, which was considered to be statistically significant.